MX2009005579A - Quinazolinas sustituidas. - Google Patents

Quinazolinas sustituidas.

Info

Publication number
MX2009005579A
MX2009005579A MX2009005579A MX2009005579A MX2009005579A MX 2009005579 A MX2009005579 A MX 2009005579A MX 2009005579 A MX2009005579 A MX 2009005579A MX 2009005579 A MX2009005579 A MX 2009005579A MX 2009005579 A MX2009005579 A MX 2009005579A
Authority
MX
Mexico
Prior art keywords
relates
present
platelet lowering
substituted quinazolines
discovery
Prior art date
Application number
MX2009005579A
Other languages
English (en)
Spanish (es)
Inventor
Richard Franklin
Bernard Golding
Original Assignee
Shire Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shire Llc filed Critical Shire Llc
Publication of MX2009005579A publication Critical patent/MX2009005579A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
MX2009005579A 2006-11-28 2007-11-19 Quinazolinas sustituidas. MX2009005579A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0623750.7A GB0623750D0 (en) 2006-11-28 2006-11-28 Substituted quinazolines
PCT/GB2007/050697 WO2008065444A2 (fr) 2006-11-28 2007-11-19 Quinazolines substituées

Publications (1)

Publication Number Publication Date
MX2009005579A true MX2009005579A (es) 2009-08-12

Family

ID=37671460

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009005579A MX2009005579A (es) 2006-11-28 2007-11-19 Quinazolinas sustituidas.

Country Status (14)

Country Link
EP (1) EP2099802A2 (fr)
JP (1) JP2010511030A (fr)
KR (1) KR20090094268A (fr)
CN (1) CN101558071B (fr)
AR (1) AR064002A1 (fr)
AU (1) AU2007327047B2 (fr)
BR (1) BRPI0719570A2 (fr)
CA (1) CA2670123A1 (fr)
EA (1) EA018259B1 (fr)
GB (1) GB0623750D0 (fr)
IL (1) IL198809A0 (fr)
MX (1) MX2009005579A (fr)
TW (1) TW200838537A (fr)
WO (1) WO2008065444A2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8304420B2 (en) 2006-11-28 2012-11-06 Shire Llc Substituted quinazolines for reducing platelet count
GB0808944D0 (en) * 2008-05-16 2008-06-25 Shire Llc Substituted quinazolines
GB2462022B (en) 2008-06-16 2011-05-25 Biovascular Inc Controlled release compositions of agents that reduce circulating levels of platelets and methods thereof
GB0822970D0 (en) 2008-12-17 2009-01-21 Shire Llc Process for the preparation of anagrelide and analogues
GB201004495D0 (en) 2010-03-18 2010-05-05 Shire Llc Subtituted quinazolines
GB201017783D0 (en) 2010-10-21 2010-12-01 Shire Llc Process for the preparation of anagrelide and analogues thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7807507A (nl) * 1977-07-25 1979-01-29 Hoffmann La Roche Tricyclische verbindingen.
CA1131631A (fr) * 1979-06-20 1982-09-14 Madhukar S. Chodnekar Derives de la quinazoline et preparations pharmaceutiques
ZA803535B (en) * 1979-06-20 1981-06-24 Hoffmann La Roche Novel quinazoline derivatives and pharmaceutical preparations
CN1738623A (zh) * 2003-01-23 2006-02-22 夏尔控股公司 治疗血小板增多症的制剂和方法
US7700608B2 (en) * 2004-08-04 2010-04-20 Shire Holdings Ag Quinazoline derivatives and their use in the treatment of thrombocythemia
US20060030574A1 (en) * 2004-08-04 2006-02-09 Shire Holdings Ag Quinazoline derivatives useful for the treatment of peripheral arterial disease and as phosphodiesterase inhibitors

Also Published As

Publication number Publication date
IL198809A0 (en) 2010-02-17
AU2007327047A1 (en) 2008-06-05
WO2008065444A3 (fr) 2008-07-31
CN101558071A (zh) 2009-10-14
EA200900740A1 (ru) 2010-02-26
CA2670123A1 (fr) 2008-06-05
KR20090094268A (ko) 2009-09-04
CN101558071B (zh) 2013-04-24
AR064002A1 (es) 2009-03-04
EA018259B1 (ru) 2013-06-28
GB0623750D0 (en) 2007-01-10
WO2008065444A2 (fr) 2008-06-05
TW200838537A (en) 2008-10-01
AU2007327047B2 (en) 2012-08-30
EP2099802A2 (fr) 2009-09-16
BRPI0719570A2 (pt) 2013-12-10
JP2010511030A (ja) 2010-04-08
WO2008065444B1 (fr) 2008-10-09

Similar Documents

Publication Publication Date Title
EA201300556A1 (ru) Аминоспиртзамещенные производные 2,3-дигидроимидазо[1,2-с] хиназолина, пригодные для лечения гиперпролиферативных нарушений и заболеваний, связанных с ангиогенезом
WO2008033562A3 (fr) Composés inhibiteurs de kinases
TW200616627A (en) New pharmaceutical compositions for the treatment of hyper-proliferative disorders
WO2010141796A3 (fr) Préparation et utilisation de dérivés de 1,2,4-triazolo[1,5a]pyridine
WO2008044217A3 (fr) Dérivés de 2-aminocarbonyl-pyridine
TNSN08283A1 (en) Cytotoxic agents comprising new tomaymycin derivatives and their therapeutic use
WO2010111406A3 (fr) Composés et leurs utilisations thérapeutiques
GEP20084452B (en) Sulfonamide derivatives for the treatment of diseases
WO2009145456A3 (fr) Dérivés hétérocycliques
TW200745136A (en) 4-Amino-thieno[3,2-c]pyridine-7-carboxylic acid derivatives
WO2009091550A3 (fr) Dérivés de 2,3-dihydroimidazo [1,2-c] quinazoline à substitution sulfone utilisés pour traiter des troubles hyperproliférants et des maladies associées à l'angiogénèse
MX2009005579A (es) Quinazolinas sustituidas.
WO2008050301A3 (fr) Dérivés de 2-phényl-6-aminocarbonyl-pyrimidine
WO2008049855A3 (fr) Nouveaux composés
WO2007076087A3 (fr) Quinazolones d'aryle substitue et leurs utilisations
MY150745A (en) Isoserine derivatives for use as coagulation factor ixa inhibitors
HK1093729A1 (en) Substituted quinolones
WO2009003719A3 (fr) Dérivés d'indane-amine, leur préparation et leur utilisation comme médicaments
WO2008116663A3 (fr) Dérivés de tétrahydro-naphtalène-amine substitués par un hétérocyclyle, leur préparation et utilisation en tant que médicaments
MX2012001529A (es) Derivados de 3-heteroaril-metil-imidazo-[1,2-b]-piridazin-6-ilo como moduladores de cinasa de tirosina c-met.
WO2006089664A3 (fr) Imidazoles substitues par heterocyclylamide
WO2010121675A3 (fr) Thiazolyl-benzimidazoles
IL196469A (en) History of triazine and their use in the preparation of drugs for the treatment of diseases
WO2009138796A3 (fr) Quinazolines substitués
TW200738611A (en) 9-Chloro-15-deoxyprostaglandin derivatives, process for their preparation and their use as medicaments

Legal Events

Date Code Title Description
HH Correction or change in general